Iron-based phosphate binders--a new element in management of hyperphosphatemia.
about
High-Iron Consumption Impairs Growth and Causes Copper-Deficiency Anemia in Weanling Sprague-Dawley Rats.Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD.Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.Phosphate binders in patients with chronic kidney disease.
P2860
Iron-based phosphate binders--a new element in management of hyperphosphatemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Iron-based phosphate binders--a new element in management of hyperphosphatemia.
@en
type
label
Iron-based phosphate binders--a new element in management of hyperphosphatemia.
@en
prefLabel
Iron-based phosphate binders--a new element in management of hyperphosphatemia.
@en
P2860
P1476
Iron-based phosphate binders--a new element in management of hyperphosphatemia
@en
P2093
Amy Barton Pai
Nicole Wegrzyn
P2860
P304
P356
10.1517/17425255.2016.1110573
P407
P50
P577
2015-11-16T00:00:00Z